BioNTech, Pfizer to develop single-dose vaccine for COVID, influenza



Pfizer and BioNTech began a study of a single-dose vaccine candidate for influenza and COVID-19, BioNTech said Thursday.

The study will combine Pfizer’s quadrivalent modRNA-based influenza vaccin…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento